ARCHIVES

Conference Explores Hype And Hope In Communicating Science News

This article is from The Cancer Letter archive.

Vol. 24 No. 19 | May 15, 1998

Download PDF Visit The Full Archive

Related Articles

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

NTP Board Approves Six New Projects, Tables One Other

January 23, 1981

President Accepts Rauscher Resignation

October 1, 1976

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

No Cancer Letter for Two Weeks

August 13, 1993